AbbVie Inc. (ABBV)
Quarterly indicator history, curated for fast reading.
Exchange
NYSE
IPO Date
Jan 2, 2013
IPO Price
$35.29
Shares Outstanding
1.77B
Market Cap
$399.42B
Price
$225.66+2.65 (+1.19%)● Live
Rule of 402025 Q3
51.2
✓ Passing
Revenue Growth YoY+9.1%
+
FCF Margin+42.1%
History
Revenue
Unit: USD · Scale: ones
2025 Q3
$15,776,000,000
EPS
Unit: USD per share · Scale: ones
2025 Q3
$0.1
P/E Ratio
Unit: x · Scale: ones
2025 Q3
172.76
Free cash flow
Unit: USD · Scale: ones
2025 Q3
$6,643,000,000
Company timeline
Earnings release dates
| Quarter | End date | Publication date | Source |
|---|---|---|---|
| 2025 Q4 | 2025-12-31 | 2026-02-04 (upcoming) | Link |
| 2025 Q3 | 2025-09-30 | 2025-10-31 | Link |
| 2025 Q2 | 2025-06-30 | 2025-07-31 | Link |
| 2025 Q1 | 2025-03-31 | 2025-04-25 | Link |
| 2024 Q4 | 2024-12-31 | 2025-01-31 | Link |
| 2024 Q3 | 2024-09-30 | 2024-10-30 | Link |
| 2024 Q2 | 2024-06-30 | 2024-07-25 | Link |
| 2024 Q1 | 2024-03-31 | 2024-04-26 | Link |
| 2023 Q4 | 2023-12-31 | 2024-02-02 | Link |
| 2023 Q3 | 2023-09-30 | 2023-10-27 | Link |
| 2023 Q2 | 2023-06-30 | 2023-07-27 | Link |
| 2023 Q1 | 2023-03-31 | 2023-04-27 | Link |
| 2022 Q4 | 2022-12-31 | 2023-02-09 | Link |
| 2022 Q3 | 2022-09-30 | 2022-10-28 | Link |
| 2022 Q2 | 2022-06-30 | 2022-07-29 | Link |
| 2022 Q1 | 2022-03-31 | 2022-04-29 | Link |
| 2021 Q4 | 2021-12-31 | 2022-02-02 | Link |
| 2021 Q3 | 2021-09-30 | 2021-10-29 | Link |
| 2021 Q2 | 2021-06-30 | 2021-07-30 | Link |
| 2021 Q1 | 2021-03-31 | 2021-04-30 | Link |
| 2020 Q4 | 2020-12-31 | 2021-02-03 | Link |
| 2020 Q3 | 2020-09-30 | 2020-10-30 | Link |
| 2020 Q2 | 2020-06-30 | 2020-07-31 | Link |
| 2020 Q1 | 2020-03-31 | 2020-05-01 | Link |
Leadership
Key Players
Robert A. Michael
Chairman of the Board & CEO
Became CEO in 2024, added Chairman role effective July 2025; previously President & COO, CFO; 30+ years at Abbott/AbbVie.
Scott T. Reents
EVP, Chief Financial Officer
Named CFO in June 2022; previously VP of Tax and Treasury; joined the company in 2013.
Jeffrey Stewart
EVP, Chief Commercial Officer
Leads global commercial operations across all therapeutic areas and the Allergan Aesthetics portfolio.
Roopal Thakkar, M.D.
EVP, R&D & Chief Scientific Officer
Appointed July 2024; leads 14,000+ R&D team members; drives pipeline across immunology, oncology, neuroscience, and eye care.
Azita Saleki-Gerhardt, Ph.D.
EVP, Chief Operations Officer
Oversees global manufacturing, supply chain, quality, and enterprise services for all AbbVie products.
Perry Siatis
EVP, General Counsel & Secretary
Promoted to General Counsel in late 2022; succeeded Laura Schumacher; previously SVP and Deputy General Counsel.
Carrie Strom
SVP, President of Global Allergan Aesthetics
Leads the Allergan Aesthetics business including Botox Cosmetic, Juvederm, CoolSculpting, and SkinMedica.
Tracie Haas
SVP, Corporate Affairs
Develops and executes global strategies for corporate reputation, communications, and government affairs.
Roxanne S. Austin
Lead Independent Director
President of Austin Investment Advisors; became Lead Independent Director in July 2024; joined board in 2018.
Robert J. Alpern, M.D.
Independent Director
Ensign Professor of Medicine and Physiology and former Dean of Yale School of Medicine; joined board in 2013.
William H.L. Burnside
Independent Director
Retired Senior Vice President and Director of The Boston Consulting Group; joined board in 2018.
Thomas C. Freyman
Independent Director
Retired EVP of Finance and Administration at Abbott Laboratories; brings extensive pharmaceutical finance expertise.
Brett J. Hart
Independent Director
President of United Airlines Holdings, Inc.; brings corporate governance and operational leadership experience.
Edward M. Liddy
Independent Director
Retired Chairman and CEO of The Allstate Corporation; joined board in 2013; insurance and financial services background.
Melody B. Meyer
Independent Director
Retired President of Chevron Asia Pacific Exploration and Production; energy industry and operations expertise.
Edward J. Rapp
Independent Director
Retired Group President for Resource Industries at Caterpillar Inc.; global operations and strategy background.
Rebecca B. Roberts
Independent Director
Retired President of Chevron Pipe Line Company; extensive experience in energy, operations, and engineering.
Frederick H. Waddell
Independent Director
Former Chairman and CEO of Northern Trust Corporation; deep expertise in finance, banking, and corporate governance.
Short Interest
Short interest data unavailable for ABBV.